HC Financial Advisors’s AstraZeneca AZN Stock Holding History

HC Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$71K	Hold	538	–	–	0.05%	113
2022 Q1	$71K	Hold	538	–	–	0.04%	115
2021 Q4	$63K	Hold	538	–	–	0.04%	127
2021 Q3	$65K	Buy	538 +288	+115%	+$33.5K	0.04%	119
2021 Q2	$30K	Hold	250	–	–	0.02%	165
2021 Q1	$25K	Hold	250	–	–	0.02%	175
2020 Q4	$25K	Hold	250	–	–	0.02%	182
2020 Q3	$27K	Hold	250	–	–	0.02%	164
2020 Q2	$26K	Hold	250	–	–	0.02%	159
2020 Q1	$22K	Buy	+250	New	+$23.5K	0.02%	167

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HC Financial Advisors's AZN Position: Q2 2022 in Review

HC Financial Advisors held its AstraZeneca (AZN) position steady in Q2 2022 at 538 shares worth $71K. The position accounts for 0.05% of the portfolio, ranked #113.

HC Financial Advisors first reported a position in AZN in Q1 2020 and has held it in 10 quarters since. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

HC Financial Advisors held 538 shares of AstraZeneca worth $71K as of Q2 2022.
HC Financial Advisors left its AstraZeneca share count unchanged in Q2 2022.
AstraZeneca made up 0.05% of HC Financial Advisors's portfolio in Q2 2022, its #113 holding.
HC Financial Advisors first reported a position in AstraZeneca in Q1 2020 and has held it in 10 quarters since.
1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on HC Financial Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.